Skip to main content
Log in

Aggressive human MenG C meningiomas have a molecular counterpart in canines

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

RNA-seq data used in this study is available in the Gene Expression Omnibus database,, under the following Accession Numbers: GSE136661 (Human), GSE189673 (Human), and GSE250310 (Canine).


  1. Bayley JC, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ (2022) Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv 8:eabm6247.

    Article  ADS  CAS  PubMed  Google Scholar 

  2. Choudhury A, Chen WC, Lucas C-HG, Bayley JC, Harmanci AS, Maas SLN et al (2023) Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol 25:520–530.

    Article  CAS  PubMed  Google Scholar 

  3. Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Seo K et al (2020) Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilities. Nat Genet 54(5):649–659.

    Article  CAS  Google Scholar 

  4. Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V et al (2022) A molecularly integrated grade for meningioma. Neuro Oncol 24:796–808.

    Article  CAS  PubMed  Google Scholar 

  5. Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119–125.

    Article  ADS  CAS  PubMed  Google Scholar 

  6. Patel AJ, Wan Y-W, Al-Ouran R, Revelli J-P, Cardenas MF, Oneissi M et al (2019) Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci USA 116:21715–21726.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  7. Patnaik AK, Kay WJ, Hurvitz AI (1986) Intracranial meningioma: a comparative pathologic study of 28 dogs. Vet Pathol 23:369–373.

    Article  CAS  PubMed  Google Scholar 

  8. Serin Harmanci A, Harmanci AO, Zhou X (2020) CaSpER identifies and visualizes CNV events by integrative analysis of single-cell or bulk RNA-sequencing data. Nat Commun 11:89.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  9. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte C (2006) Canine intracranial primary neoplasia: 173 cases (1986–2003). J Vet Intern Med 20:669–675.[669:cipnc];2

    Article  PubMed  Google Scholar 

  10. Song RB, Vite CH, Bradley CW, Cross JR (2013) Postmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weight. J Vet Intern Med 27:1143–1152.

    Article  CAS  PubMed  Google Scholar 

  11. Sturges BK, Dickinson PJ, Bollen AW, Koblik PD, Kass PH, Kortz GD et al (2008) Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med 22:586–595.

    Article  CAS  PubMed  Google Scholar 

  12. Troxel MT, Vite CH, Van Winkle TJ, Newton AL, Tiches D, Dayrell-Hart B et al (2003) Feline intracranial neoplasia: retrospective review of 160 cases (1985–2001). J Vet Intern Med 17:850–859.

    Article  PubMed  Google Scholar 

  13. Zhang H, Qi L, Du Y, Huang LF, Braun FK, Kogiso M et al (2020) Patient-Derived Orthotopic Xenograft (PDOX) mouse models of primary and recurrent meningioma. Cancers (Basel).

    Article  PubMed  PubMed Central  Google Scholar 

Download references


We thank the patients and owners who entrusted us with care and participated in this study. This work was supported by the NINDS (K08NS102474 to AJP) and the Roderick D. MacDonald Fund (AJP).

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Tiemo J. Klisch, Jonathan M. Levine or Akash J. Patel.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest related to this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harmanci, A.S., Boudreau, B., Lau, S. et al. Aggressive human MenG C meningiomas have a molecular counterpart in canines. Acta Neuropathol 147, 42 (2024).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: